Duroflo II heparin bonding does not attenuate cytokine release or improve pulmonary function
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 74 (1) , 139-142
- https://doi.org/10.1016/s0003-4975(02)03594-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Inflammatory Response to Cardiopulmonary BypassChest, 1997
- Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patientsAmerican Heart Journal, 1997
- Cytokine Responses to Cardiopulmonary Bypass: Lessons Learned From Cardiac TransplantationThe Annals of Thoracic Surgery, 1997
- The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failureThe American Journal of Surgery, 1996
- Regulatory effects of interleukin-10 on lung ischemia-reperfusion injuryThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1995
- Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- Inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- Interleukin-6: An OverviewAnnual Review of Immunology, 1990